medigraphic.com
SPANISH

Archivos de Cardiología de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number s2

<< Back Next >>

Arch Cardiol Mex 2004; 74 (s2)

Restenosis: Prevention and treatment

Macaya C
Full text How to cite this article

Language: Spanish
References: 10
Page: 406-409
PDF size: 50.61 Kb.


Key words:

Coronary restenosis, Stents, Sirolymus, Taxol.

ABSTRACT

Coronary restenosis after angioplasty has been considered as a main sequel to be resolved so success can be guaranteed. Stents procedures represent a partial solution which is favored with the application of drug-releasing stents of drugs such as sirolymus and taxol.


REFERENCES

  1. Serruys PW, de Jaegere P, Kiemeneij F, et al: A comparison of balloon expandable-stent implantation with ballon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.

  2. Hoffmann R, Mintz GS, Dussaillant Gr, et al: Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 1996; 94: 1247-54.

  3. de Feyter PJ, Vos J, Rensing BJ: Anti-restenosis trials. Curr Inter Cardiol Rep 2000; 2: 326-31.

  4. Suzuki T, Kopia G, Hayashi S, et al: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-93.

  5. Sousa JE, Costa MA, Abizaid A, et al: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-5.

  6. Sousa JE, Costa MA, Sousa AG, et al: Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003; 107: 381-383.

  7. Marie Claude Morice, Patrick W. Serruys J, Eduardo Sousa, et al: N Engl J Med 2002; 346: 1773-80.

  8. Park SJ, Shim WH, Ho DS, et al: A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537-1545.

  9. Moses JW, Leon MB, Popma JJ, et al: Sirolimus eluting stents versus standard stents in patients with restenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.

  10. Schofer J, Schulter M, Gershlich AH, et al: Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362: 1093-1099.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Cardiol Mex. 2004;74